Physician profile
Brandy Bauer
NPI 1306330105
$574.29
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $574.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.77 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $100.30 | 2021 | |
| Janssen Pharmaceuticals, INC | $58.65 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.17 | 2021 | |
| Amneal Pharmaceuticals LLC | $40.47 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.99 | 2021 | |
| Amgen INC. | $23.01 | 2021 | |
| Therapeuticsmd, INC. | $19.46 | 2021 | |
| Alfasigma USA, INC. | $14.76 | 2021 | |
| Merck Sharp & Dohme LLC | $14.70 | 2021 | |
| Lilly USA, LLC | $14.70 | 2021 | |
| Pfizer INC. | $14.19 | 2021 | |
| Glaxosmithkline, LLC. | $14.09 | 2021 | |
| Daiichi Sankyo INC. | $14.03 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.